Obesity: Drugs
Commons · Question 67565 · Tabled 14 Jul 2025 · Department of Health and Social Care · Official record
Answered 25 Jul 2025
Question
Asked by Andrew Snowden
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure equitable access to weight loss drugs across NHS trusts.
Answer
Answered by Ashley Dalton, 25 Jul 2025
The medicines liraglutide, under various brand names, semaglutide, brand name Wegovy, and tirzepatide, brand name Mounjaro, are already being made available for managing obesity for some patients attending National Health Service specialist weight managem...